טוען...
Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus—the glass is half full!
Biomarkers for prognostication need large randomised controlled trials such as AspECT and BOSS. These trials will deliver surrogates which fulfil the validation criteria necessary for their introduction into the clinic
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1856442/ https://ncbi.nlm.nih.gov/pubmed/16966694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2006.096461 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|